GlassScriptPhysician profile
Karen Slabas
NPI 1629370705
$5,627.01
in general payments reported to CMS, 2019-2025
28 companies · $769 in 2025
The $769 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $60.09 · 2021: $21.36 · 2022: $272 · 2023: $3,866 · 2024: $509 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,137 · Food and Beverage: $1,823 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,136.97 |
| Food and Beverage | $1,822.89 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $3,498.62 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Astellas Pharma US INC | $656.77 | 2023-2025 | Veozah |
| Organon LLC | $169.48 | 2023-2025 | Nexplanon |
| Olympus America INC. | $167.94 | 2022 | |
| Mayne Pharma Commercial LLC | $149.72 | 2024-2025 | |
| Axonics, INC. | $125.93 | 2022-2024 | Bulkamid, Axonics |
| Abiomed | $120.63 | 2025 | |
| Hologic Sales and Service, LLC | $107.14 | 2019-2023 | Acessa Provu System, Coolseal Generator |
| Millicent US INC | $72.32 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Allergan, INC. | $60.09 | 2020 | |
| Sumitomo Pharma America, INC. | $51.30 | 2023-2025 | Myfembree |
| Boston Scientific Corporation | $45.95 | 2019-2025 | Axonics |
| Vertical Pharmaceuticals, LLC | $41.67 | 2019 | |
| Exeltis, USA INC. | $35.65 | 2022-2025 | Slynd |
| Abbvie INC. | $35.28 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $33.32 | 2025 | Vistaseal, Stratafix |
| Pfizer INC. | $33.08 | 2024 | |
| Therapeuticsmd, INC. | $30.16 | 2019-2022 | |
| Meditrina | $27.18 | 2022-2023 | |
| Mimedx Group, INC. | $24.58 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $23.47 | 2025 | |
| Merck Sharp & Dohme LLC | $21.29 | 2024 | Gardasil 9, Gardasil |
| Smith+Nephew, INC. | $19.99 | 2025 | Pico 14 |
| Coopersurgical, INC. | $17.93 | 2019 | |
| Shield Therapeutics INC | $16.04 | 2024 | |
| Avion Pharmaceuticals | $14.83 | 2022 | |
| Agile Therapeutics, INC. | $13.33 | 2024 | Twirla |
| Minerva Surgical, INC | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Slabas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.